Furthermore, we observed that the downregulation of ASM expression increased TFEB nuclear translocation (Figure S4B) and prevented myocardial hypertrophy, an effect that was enhanced when combined with PUE treatment (Figure 6E,G). This evidence concerns the gene SMPD1 and cardiac hypertrophy.